Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT07086469 · RECRUITING
Trial details
- NCT number
- NCT07086469
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-20
- Primary completion
- 2029-07-19
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.